Fiona Kate Rice

Fiona Kate Rice

Auto-generated profile, based on publicly available information

Fiona Kate Rice

Department of Psychiatry, Center for Mindfulness and Compassion, Cambridge Health Alliance, 350 Main Street, Suite 5126, Malden, MA, 02148, United States, 1 617-591-6056

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in JMIR Preprints
Verified
Preprint
Open access
LVLiv Valö
Liv Valö
JRJoseph Rosansky
Joseph Rosansky
GPGareth Parry
Gareth Parry
ACAlexandra Comeau
Alexandra Comeau
FRFiona Kate Rice
Fiona Kate Rice
ZSZev Schuman-Olivier
Zev Schuman-Olivier
BACKGROUND The COVID-19 pandemic highlighted a critical need for effective population mental health approaches to target the most prevalent disorders, such as depression, during periods of elevated community distress. Studies investigating the effectiveness of remotely-delivered and web-based interventions are needed to identify and innovate high-quality models for population mental health service delivery. OBJECTIVE To compare the effectiveness of two transdiagnostic treatments, Mindfulness-Based Cognitive Therapy for Resilience (MBCT-R; remotely-delivered) and iCBT (web-based), with a low-intensity control condition, CHAMindWell (CHA-MW), a web-based population health screening and stratified support program, on depression symptom severity. METHODS Participants (N=97) were randomized in a 2:2:1 ratio to MBCT-R + CHA-MW (n=37), iCBT + CHA-MW (n=41), or CHA-MW alone (n=19) in a comparative effectiveness trial occurring from May 2021 to February 2023 in an urban public safety net hospital setting. MBCT-R was an 8-session, synchronous, online group curriculum that integrated mindfulness training and cognitive behavioral therapy to address COVID-19-related psychosocial stressors associated with increased risk for depression. iCBT was a 6-session, asynchronous, individual cognitive-behavioral therapy online curriculum for depression and anxiety. Both programs were supported by and compared with CHA-MW, an integrated web-based population health monitoring and response program. MBCT-R + CHA-MW and iCBT + CHA-MW were roughly time and attention matched, while CHA-MW alone was employed as a low-intensity control condition. All study procedures, including regular mental health symptom screenings, were conducted remotely or via a web-based platform. The primary outcome was change in depression symptom severity during the 24-week study period using an intention-to-treat approach that employed generalized linear mixed effects models to evaluate the comparative effectiveness of the three intervention arms over time. Secondary and exploratory outcomes included mental health clinician visits used during the 24-week study period as well as changes in anxiety, perceived stress, interoception, experiential avoidance, emotional dysregulation, self-compassion, and decentering. RESULTS For the primary outcome, results indicated significant reductions in depression symptom severity across all treatment arms (MBCT-R mean difference=-14.1 (95% CI [-21,-7.2]; iCBT mean difference=-12.7 (95% CI [-17.4, -8.1], CHA-MW mean difference=-15.2 (95% CI [-21.8, -8.6]) but no statistically significant between-group differences. For the secondary outcome, findings indicated no statistically significant differences in mental health clinician visits by group. Exploratory analyses demonstrated statistically significant improvement in mental health outcomes across all treatment arms with no significant between-group differences. CONCLUSIONS This study demonstrated moderate to large effect size improvements in depression and exploratory mental health outcomes. However, it did not identify the superiority of any intervention, suggesting that CHA-MW, a low-intensity, resource-efficient, web-based, population mental health program, is a promising approach to mental wellness during times of high community distress with or without additional higher intensity remote interventions. CLINICALTRIAL NCT04595084

4 August 2026 in JMIR Mental Health
Verified
Journal Article
Open access
ZSZev Schuman-Olivier
Zev Schuman-Olivier
LVLiv Valö
Liv Valö
JRJoseph A Rosansky
Joseph A Rosansky
GPGareth Parry
Gareth Parry
ACAlexandra Comeau
Alexandra Comeau
CFCarl Fulwiler
Carl Fulwiler
Background: The COVID-19 pandemic highlighted a critical need for effective population mental health approaches to target the most prevalent disorders (eg, depression) during periods of elevated community distress. The effectiveness of remotely delivered and web-based interventions should be investigated to identify and innovate high-quality models for population mental health service delivery. Objective: The primary objective investigated the effectiveness of adding Mindfulness-Based Cognitive Therapy for Resilience (MBCT-R)—a live, online, synchronous, remotely delivered, group-based intervention—to Cambridge Health Alliance MindWell (CHA-MW), a web-based population health screening and stratified support program, compared with CHA-MW alone, on depression symptom severity. The secondary objective evaluated adding internet Cognitive Behavioral Therapy (iCBT)—an asynchronous, web-based, individual, digital intervention—to CHA-MW, compared with CHA-MW alone. Methods: Participants (N=97) were randomized in a 2:2:1 ratio to receive MBCT-R+CHA-MW (n=37), iCBT+CHA-MW (n=41), or CHA-MW alone (n=19) in a 3-arm randomized clinical trial, from May 2021 to September 2022 in an urban public safety net hospital outpatient setting. CHA-MW served as a low-intensity control condition. For the MBCT-R+CHA-MW arm, MBCT-R was an 8-session program mildly adapted from MBCT to address COVID-19–related risks for depression. For the iCBT+CHA-MW arm, iCBT was a 6-session curriculum added to CHA-MW. All study procedures, including regular mental health symptom screenings, were conducted remotely or via a web-based platform. The primary outcome was change in depression symptom severity during the 24-week study period using an intention-to-treat approach that used generalized linear mixed-effects models to evaluate the comparative effectiveness of MBCT-R+CHA-MW vs CHA-MW over time. A secondary analysis compared iCBT+CHA-MW vs CHA-MW on depression severity. Completer analyses were conducted (per-protocol 6+ sessions). The secondary outcome was mental health visit utilization frequency during the study period. Results: Both MBCT-R+CHA-MW (mean difference −14.1, 95% CI −21.0 to −7.2) and CHA-MW (mean difference −15.2, 95% CI −21.8 to −8.6) had significant reductions in depression symptom severity, with no statistically significant between-group differences. iCBT+CHA-MW (mean difference −12.7, 95% CI −17.4 to −8.1) also reduced depression symptoms but without between-group differences when compared with CHA-MW. Intervention completion rates were low (MBCT-R: 30% and iCBT: 24%), and completers demonstrated significantly greater reductions in depression severity than noncompleters (mean difference −8.5, 95% CI −16.2 to −0.8). Overall mental health clinician visits by group had no statistically significant differences. CHA-MW had the largest increase in participants with new psychopharmacology treatment visits during the 24-week study (CHA-MW +21%, MBCT-R +10%, and iCBT −5%). Conclusions: MBCT-R+CHA-MW, iCBT+CHA-MW, and CHA-MW were each effective in treating depression, without any intervention demonstrating superiority in intention-to-treat analyses. CHA-MW was as efficacious during the COVID-19 pandemic as more resource-intensive interventions that demanded greater time and effort from participants. Low completion rates for MBCT-R and iCBT during the COVID-19 pandemic may have contributed to these results.